Event Abstract Back to Event 3D printing biomimetic nanomaterials for highly efficient vascularized bone development Benjamin Holmes1*, Michael Plesniak1* and Grace Zhang1, 2, 3 1 The George Washington University, Mechanical and Aerospace Engineering, United States 2 The George Washington University, Department of Biomedical Engineering, United States 3 The George Washington University, Division of Genomic Medicine, Department of Medicine, United States Introduction: Large critical sized bone defects are notoriously hard to regenerate due to the need for such large and complex portions of tissue to have an adequate vascular network. As an emerging tissue fabrication technique, 3D bioprinting offers great precision to control the internal architecture of a scaffold and print complicated structures close in architecture to biological tissue[1]. Thus, the objective of this study is to combine a microvascular 3D printed design with biomimetic nanomaterials (i.e., bone minerals, nanocrystalline hydroxyapatite (nHA) and growth factor loaded nanospheres) for highly efficient fluid perfusion and enhanced vascularized bone regeneration. Materials and Methods: Two types of scaffolds with both large (500 µm radius) and small (250 µm radius) fluid microchannels (Figure 1) were designed and 3D printed via fused deposition molding printing from biocompatible polylactic acid (PLA). Biomimetic osteogenic nHA and angiogenic vascular endothelial growth factor (VEGF) loaded PLGA nanospheres were fabricated and then conjugated onto the 3D printed scaffolds using a multi-step aminolysis process. The scaffolds were characterized via scanning electron microscopy (SEM). The VEGF release from the scaffolds was characterized for 7 days. Both human umbilical vein endothelial cell (HUVECs) and human bone marrow mesenchymal stem cell (hMSCs) functions in the 3D printed scaffolds were investigated in vitro. Figure 1; Computer aided designs (CAD) of large (left) and right (small) microvascular channel bone scaffolds. Results and Discussion: SEM showed that the conjugation of nanomaterials had a noticeable effect on the nano-topography when compared to untreated PLA. 7 day VEGF release study showed a slow release rate after 48 hours on scaffolds with VEGF encapsulated nanospheres, when compared to bare VEGF samples. In addition, the scaffolds with larger microchannels and a smaller PLGA nanosphere concentration both provide a more efficient mechanism for HUVEC cell invasion and proliferation. Figure 2 shows hMSC 3 week differentiation on scaffolds with pre-cultured HUVEC vascular networks. Figure 2; 1, 2 and 3 week calcium deposition of hMSCs cultured on scaffolds which have been pre-cultured with HUVECs for 1 week. Data are ± standard error of the mean, N=3; *p<0.05 when compared to all other groups at weeks 1 and 2, respectively; **p<0.05 when compared to scaffolds with large and small microchannels at week 1; ***p<0.05 when compared to scaffolds with small microchannels at week 3; and #p<0.05 when compared to all other groups at week 3. Excellent calcium deposition was exhibited on scaffolds with both VEGF loaded PLGA nanospheres and nHA. Yet, higher values in calcium were seen on samples with only PLGA nanospheres, when compared to plain PLA controls. A similar trend could be observed for collagen type I synthesis on scaffolds. In both cases, higher amount of bone matrix deposited can be attributed to the presence of nHA, but it can also be inferred that the presence of VEGF and HUVECs induced cell to cell interactions which also lead to faster bone tissue formation. Conclusion: Based on these results, it can be inferred that the use of a drug loaded nanoparticle delivery system, along with nHA, a bioactive conjugation method and highly efficient 3D printed micro designs for cell growth, infiltration and fluid perfusion can yield a highly effective method for the enhanced growth of vascularized bone.
Read full abstract